A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Clinical trial NCT06775405 · RECRUITING
Trial details
- NCT number
- NCT06775405
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2025-08-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.